Metabolic Engineering of Escherichia coli for High-Yield Production of (R)-1,3-Butanediol

Yu Liu, Xuecong Cen, Dehua Liu, Zhen ChenACS 2021 · DOI

Abstract

1,3-Butanediol (1,3-BDO) is an important C4 platform chemical widely used as a solvent in cosmetics and a key intermediate for the synthesis of fragrances, pheromones, and pharmaceuticals. The development of sustainable bioprocesses to produce enantiopure 1,3-BDO from renewable bioresources by fermentation is a promising alternative to conventional chemical routes and has aroused great interest in recent years. Although two metabolic pathways have been previously established for the biosynthesis of (<i>R</i>)-1,3-PDO, the reported titer and yield are too low for cost-competitive production. In this study, we report the combination of different metabolic engineering strategies to improve the production of (<i>R</i>)-1,3-BDO by <i>Escherichia coli</i>, including (1) screening of key pathway enzymes; (2) increasing NADPH supply by cofactor engineering; (3) optimization of fermentation conditions to divert more flux into 1,3-BDO pathway; (4) reduction of byproducts formation by pathway engineering. With these efforts, the best engineered <i>E. coli</i> strain can efficiently produce (<i>R</i>)-1,3-BDO with a yield of 0.6 mol/mol glucose, corresponding to 60% of the theoretical yield. Besides, we also showed the feasibility of aerobically producing 1,3-BDO via a new pathway using 3-hydroxybutyrate as an intermediate.
BibTeX
@inproceedings{liu2021metabolic,
  author = {Yu Liu and Xuecong Cen and Dehua Liu and Zhen Chen},
  title = {{Metabolic Engineering of <i>Escherichia coli</i> for High-Yield Production of (<i>R</i>)-1,3-Butanediol}},
  booktitle = {ACS},
  year = {2021},
  doi = {10.1021/acssynbio.1c00144},
}

Loading related content...

Figure